BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tietz-Bogert PS, Kim M, Cheung A, Tabibian JH, Heimbach JK, Rosen CB, Nandakumar M, Lazaridis KN, LaRusso NF, Sung J, O'Hara SP. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis. Int J Mol Sci 2018;19:E3188. [PMID: 30332763 DOI: 10.3390/ijms19103188] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Batista LF, Holland BP. Liver Abnormalities in Cattle. Veterinary Clinics of North America: Food Animal Practice 2022;38:347-360. [DOI: 10.1016/j.cvfa.2022.08.002] [Reference Citation Analysis]
2 Walker DI, Juran BD, Cheung AC, Schlicht EM, Liang Y, Niedzwiecki M, LaRusso NF, Gores GJ, Jones DP, Miller GW, Lazaridis KN. High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases. Hepatol Commun 2021. [PMID: 34825528 DOI: 10.1002/hep4.1871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Huang Y, Zhou P, Liu S, Duan W, Zhang Q, Lu Y, Wei X. Metabolome and microbiome of chronic periapical periodontitis in permanent anterior teeth: a pilot study. BMC Oral Health 2021;21:599. [PMID: 34814909 DOI: 10.1186/s12903-021-01972-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Haal S, Guman MSS, Acherman YIZ, Jansen JPG, van Weeghel M, van Lenthe H, Wever EJM, Gerdes VEA, Voermans RP, Groen AK. Gallstone Formation Follows a Different Trajectory in Bariatric Patients Compared to Nonbariatric Patients. Metabolites 2021;11:682. [PMID: 34677397 DOI: 10.3390/metabo11100682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Desterke C, Feray C. NR0B2 regulation during Primary Sclerosing Cholangitis defines a metabolic and pre-malignant reprogramming of Cholangiocyte.. [DOI: 10.1101/2021.09.06.459063] [Reference Citation Analysis]
6 Sokolova M, Yang K, Hansen SH, Louwe MC, Kummen M, Hov JER, Sjaastad I, Berge RK, Halvorsen B, Aukrust P, Yndestad A, Ranheim T. NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet. Sci Rep 2020;10:21006. [PMID: 33273482 DOI: 10.1038/s41598-020-76497-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
7 Valestrand L, Berntsen NL, Zheng F, Schrumpf E, Hansen SH, Karlsen TH, Blumberg RS, Hov JR, Jiang X, Melum E. Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells. Clin Exp Immunol 2021;203:304-14. [PMID: 33089489 DOI: 10.1111/cei.13541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Avela HF, Sirén H. Advances in analytical tools and current statistical methods used in ultra-high-performance liquid chromatography-mass spectrometry of glycero-, glycerophospho- and sphingolipids. International Journal of Mass Spectrometry 2020;457:116408. [DOI: 10.1016/j.ijms.2020.116408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Qin Y, Méric G, Long T, Watrous JD, Burgess S, Havulinna AS, Ritchie SC, Brożyńska M, Jousilahti P, Perola M, Lahti L, Niiranen T, Cheng S, Salomaa V, Jain M, Inouye M. Genome-wide association and Mendelian randomization analysis prioritizes bioactive metabolites with putative causal effects on common diseases.. [DOI: 10.1101/2020.08.01.20166413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Avela HF, Sirén H. Advances in lipidomics. Clin Chim Acta 2020;510:123-41. [PMID: 32622966 DOI: 10.1016/j.cca.2020.06.049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
11 Rahal HK, Tabibian JH. The MBOAT7 rs641738 variant in primary sclerosing cholangitis: A novel biomarker for prognostication. Clin Res Hepatol Gastroenterol 2020;44:619-21. [PMID: 31924553 DOI: 10.1016/j.clinre.2019.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Iravani S, Dooghaie-Moghadam A, Razavi-Khorasani N, Moazzami B, Dowlati Beirami A, Mansour-Ghanaei A, Majidzadeh-A K, Mehrvar A, Khoshdel A, Nasiri Toosi M, Sadeghi A. An update on treatment options for primary sclerosing cholangitis. Gastroenterol Hepatol Bed Bench 2020;13:115-24. [PMID: 32308932] [Reference Citation Analysis]
13 Mindikoglu AL, Coarfa C, Opekun AR, Shah VH, Arab JP, Lazaridis KN, Putluri N, Ambati CR, Robertson MJ, Devaraj S, Jalal PK, Rana A, Goss JA, Dowling TC, Weir MR, Seliger SL, Raufman JP, Bernard DW, Vierling JM. Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Future Sci OA 2019;6:FSO441. [PMID: 32025330 DOI: 10.2144/fsoa-2019-0124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Fabris L, Spirli C, Mertens J. Cell Interactions in Biliary Diseases: Clues from Pathophysiology and Repair Mechanisms to Foster Early Assessment. Int J Mol Sci 2019;20:E3961. [PMID: 31416247 DOI: 10.3390/ijms20163961] [Reference Citation Analysis]